Ipca Laboratories Ltd NSE  /  BSE

Pharmaceuticals, Large Cap

25 May 2018 | 03:59 PM

668.95
7.70 (1.16%)

  • Outperforms Index

    37.07%

    Return (1Y)

    Beaten S&P BSE Healthcare by 41.82%

  • More Volatile

    2.48%

    Standard Deviation (1Y)

    Higher than S&P BSE Healthcare by 1.42%

  • Consistent Performer

    7/12

    Months

    beaten S&P BSE Healthcare

  • AxisDirect View

52 Week High-Low

757

757.00

400

400.00

News & Announcements

Price vs Volume

Stock Trivia

  • FII shareholding in Ipca Laboratories Ltd has increased by 14.09% since past 3 Months

  • MF shareholding in Ipca Laboratories Ltd has decreased by -7.53% since past 3 Months

  • GovT shareholding in Ipca Laboratories Ltd has decreased by -100% since past 3 Months

  • FII shareholding in Ipca Laboratories Ltd has increased by 5.61% since past 1 Year

Loading...